Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein

被引:27
作者
AlAbed, Y
Liebich, H
Voelter, W
Bucala, R
机构
[1] PICOWER INST MED RES, MANHASSET, NY 11030 USA
[2] UNIV TUBINGEN, D-72076 TUBINGEN, GERMANY
关键词
D O I
10.1074/jbc.271.6.2892
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Advanced glycosylation end products (AGEs) have been identified to be present on both the apolipoprotein and lipid components of low density lipoprotein (LDL) and to act to prevent its recognition and uptake by high affinity, tissue LDL receptors. Lipid-linked AGEs form readily in vitro by the covalent addition of glucose to the amine-containing head groups of phospholipids. This process is accompanied by oxidation of the unsaturated fatty acid side chains and occurs in the absence of exogenously added transition metals or free radical generating systems, suggesting that AGE formation may contribute significantly to lipid oxidation in vivo. To assess more precisely the chemical basis of AGE induced oxidative modification, we performed gas chromatography-mass spectrometry analysis of the lipid products which form over time during LDL-advanced glycosylation in vitro. Negative ion chemical ionization mass spectroscopy of two major compounds that were identified were consistent with the structures of the fatty acid oxidation products 4-hydroxyhexenal and 4-hydroxynonenal. These data support the concept that AGE formation in close proximity to unsaturated fatty acyl groups leads to lipid oxidation and provide additional evidence that advanced glycosylation is an important pathogenic modification of the LDL particle in vivo.
引用
收藏
页码:2892 / 2896
页数:5
相关论文
共 33 条
[1]  
ARAKI N, 1992, J BIOL CHEM, V267, P10211
[2]   LIPOPROTEIN DISORDERS IN DIABETES-MELLITUS [J].
BROWN, WV .
MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (01) :143-161
[3]  
Bucala R, 1992, Adv Pharmacol, V23, P1
[4]   LIPID ADVANCED GLYCOSYLATION - PATHWAY FOR LIPID OXIDATION IN-VIVO [J].
BUCALA, R ;
MAKITA, Z ;
KOSCHINSKY, T ;
CERAMI, A ;
VLASSARA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6434-6438
[5]   IDENTIFICATION OF THE MAJOR SITE OF APOLIPOPROTEIN-B MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS BLOCKING UPTAKE BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR [J].
BUCALA, R ;
MITCHELL, R ;
ARNOLD, K ;
INNERARITY, T ;
VLASSARA, H ;
CERAMI, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10828-10832
[6]   MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY ADVANCED GLYCATION END-PRODUCTS CONTRIBUTES TO THE DYSLIPIDEMIA OF DIABETES AND RENAL-INSUFFICIENCY [J].
BUCALA, R ;
MAKITA, Z ;
VEGA, G ;
GRUNDY, S ;
KOSCHINSKY, T ;
CERAMI, A ;
VLASSARA, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9441-9445
[7]   TRANSPOSITION OF AN ALU-CONTAINING ELEMENT INDUCED BY DNA-ADVANCED GLYCOSYLATION ENDPRODUCTS [J].
BUCALA, R ;
LEE, AT ;
ROURKE, L ;
CERAMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2666-2670
[8]  
BUCALA R, 1994, RES METHODOLOGIES 1, P273
[9]  
CHAN L, 1992, J BIOL CHEM, V267, P25621
[10]   CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES [J].
ESTERBAUER, H ;
SCHAUR, RJ ;
ZOLLNER, H .
FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) :81-128